Filter
1740
Text search:
profiles
Featured
171
432
Language
Document type
828
335
298
86
83
43
27
17
14
5
2
2
Countries / Regions
91
59
44
35
31
29
29
28
28
27
27
27
24
23
21
21
19
18
17
17
16
16
16
16
14
14
13
13
13
13
12
12
11
10
10
10
10
9
9
8
8
8
8
8
8
7
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
628
168
117
106
92
22
17
Toolboxes
143
125
125
95
65
62
60
53
49
47
39
38
37
36
26
25
24
22
16
13
9
8
7
7
6
Rapid review and case studies from Member States
SCOPING QUESTION: In the management of prescription opioid dependence, does supervised dosing with a long-acting opioid medication result in less opioid use and related harms than non-prescription, detoxification or usual care?
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
New criteria for classifying and diagnosing hyperglycaemia first detected during pregnancy have been accepted by a group of experts convened by WHO. These new criteria are an update of recommendations published by WHO in 1999
A stated objective of WHO’s European Mental Health Action Plan 2013–2020 is to ensure better information and knowledge for service planning, development, monitoring and evaluation, including requesting Member States to report on the indicators in the Plan.
Progress towards achieving the int
...
The disaster and Red Cross Red Crescent response to date
9 March 2019: Tropical Cyclone Idai forms over Northern Mozambique Channel. CVM preparedness and early warning actions underway
13 March 2019: IFRC Surge Capacity is deployed to Maputo
14 March 2019: 342,562 Swiss francs allocated from th
...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
Introduction
Chapter A.3
Introduction
Chapter A.4
2017 edition
Developmental disorders
Chapter C.3
Mood disorders
Chapter E.2
Anxiety disorders
Chapter F.1
2018 edition
Anxiety disorders
Chapter F.2
Other disorders
Chapter H.3
Other disorders
Chapter H.5
Other
Chapter H.4
2015 edition
Other disorders
Chapter H.5.1
